Skip to content

Clinical trials

Phase 2 Fatty Liver trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Phase: Phase 2 Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20051
20064
20078
20105
20111
20126
20132
20152
20162
20173
20182
20195
20202
20216
20224
20233
20246
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting9
Terminated8
Unknown status4
Active, not recruiting3
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Tehran University of Medical Sciences5
Metacrine, Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
Sagimet Biosciences Inc.2
Shanghai Municipal Hospital of Traditional Chinese Medicine2
89bio, Inc.1
Abhimanyu Garg1
Adrian Vella1
Ain Shams University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver70
Non-alcoholic Fatty Liver Disease51
Insulin Resistance13
Diabetes Mellitus11
Liver Diseases11
Fibrosis10
Obesity8
Diabetes Mellitus, Type 26
Digestive System Diseases5
Liver Cirrhosis4

Trials

Showing 76 to 70 of 70. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.